These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33679690)

  • 1. Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection.
    Longet S; Mellors J; Carroll MW; Tipton T
    Front Immunol; 2020; 11():599568. PubMed ID: 33679690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 3. Ebola vaccines for mass immunisation in affected regions.
    Agnandji ST; Loembe MM
    Lancet Infect Dis; 2022 Jan; 22(1):8-10. PubMed ID: 34529960
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
    Mbala-Kingebeni P; Villabona-Arenas CJ; Vidal N; Likofata J; Nsio-Mbeta J; Makiala-Mandanda S; Mukadi D; Mukadi P; Kumakamba C; Djokolo B; Ayouba A; Delaporte E; Peeters M; Muyembe Tamfum JJ; Ahuka-Mundeke S
    Clin Infect Dis; 2019 Jan; 68(2):330-333. PubMed ID: 29961823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins.
    Koch T; Rottstegge M; Ruibal P; Gomez-Medina S; Nelson EV; Escudero-Pérez B; Pillny M; Ly ML; Koundouno FR; Bore JA; Magassouba N; Dahlke C; Günther S; Carroll MW; Addo MM; Muñoz-Fontela C
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32825479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine.
    Kasereka MC; Sawatzky J; Hawkes MT
    Vaccine; 2019 Apr; 37(16):2174-2178. PubMed ID: 30878249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ebola, the first vaccines available].
    Martin B; Volchkov V; Reynard O
    Med Sci (Paris); 2020 Nov; 36(11):1027-1033. PubMed ID: 33151849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebola virus vaccines - reality or fiction?
    Mire CE; Geisbert TW; Feldmann H; Marzi A
    Expert Rev Vaccines; 2016 Nov; 15(11):1421-1430. PubMed ID: 27078187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
    Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of vaccine-induced protective immunity against Ebola virus disease.
    Medaglini D; Santoro F; Siegrist CA
    Semin Immunol; 2018 Oct; 39():65-72. PubMed ID: 30041831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola vaccine trials: progress in vaccine safety and immunogenicity.
    Matz KM; Marzi A; Feldmann H
    Expert Rev Vaccines; 2019 Dec; 18(12):1229-1242. PubMed ID: 31779496
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo.
    Rupani N; Ngole ME; Lee JA; Aluisio AR; Gainey M; Perera SM; Ntamwinja LK; Matafali RM; Muhayangabo RF; Makoyi FN; Laghari R; Levine AC; Kearney AS
    Emerg Infect Dis; 2022 Jun; 28(6):1180-1188. PubMed ID: 35608607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic science and the Ebola virus infection epidemic.
    DeVane CL
    Pharmacotherapy; 2014 Nov; 34(11):1115-7. PubMed ID: 25382095
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Make Ebola a thing of the past': first vaccine against deadly virus approved.
    Callaway E
    Nature; 2019 Nov; 575(7783):425-426. PubMed ID: 31745354
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of vaccines for prevention of Ebola virus infection.
    Ye L; Yang C
    Microbes Infect; 2015 Feb; 17(2):98-108. PubMed ID: 25526819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus disease: current vaccine solutions.
    Tomori O; Kolawole MO
    Curr Opin Immunol; 2021 Aug; 71():27-33. PubMed ID: 33873076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola in eastern DRC.
    Rollin PE
    Lancet Infect Dis; 2019 Oct; 19(10):1049-1050. PubMed ID: 31402103
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ebola virus (
    Dolzhikova IV; Shcherbinin DN; Logunov DY; Gintsburg AL
    Vopr Virusol; 2021 Mar; 66(1):7-16. PubMed ID: 33683061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.